Osaka, Japan

Sumio Matzno

This inventor holds 2 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1993-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sumio Matzno. Retrieved from https://idiyas.com/inventor/sumio-matzno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1993-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sumio Matzno: Innovator in Aminopyridine Compounds

Introduction

Sumio Matzno is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmacology, particularly through his work on aminopyridine compounds. With a total of two patents to his name, Matzno's innovations are aimed at improving drug efficacy while minimizing side effects.

Latest Patents

Matzno's latest patents focus on aminopyridine compounds that exhibit excellent pharmacological effects for treating circulatory diseases. The first patent describes an aminopyridine compound represented by a specific formula, where various substituents are defined to enhance its therapeutic properties. This compound is designed to be effective while reducing adverse side effects. The second patent also details another aminopyridine compound with a similar structure, emphasizing its potential as a drug for circulatory diseases, again highlighting its pharmacological benefits and reduced side effects.

Career Highlights

Sumio Matzno is currently associated with The Green Cross Corporation, where he continues to innovate in the field of medicinal chemistry. His work has garnered attention for its potential impact on drug development and patient care.

Collaborations

Matzno has collaborated with notable coworkers such as Tadahiro Takemoto and Masahiro Eda, contributing to a dynamic research environment that fosters innovation.

Conclusion

Sumio Matzno's contributions to the field of pharmacology through his aminopyridine compounds represent a significant advancement in drug development. His work continues to pave the way for more effective treatments for circulatory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…